Viewing Study NCT03909295


Ignite Creation Date: 2025-12-24 @ 1:49 PM
Ignite Modification Date: 2026-01-01 @ 10:21 AM
Study NCT ID: NCT03909295
Status: TERMINATED
Last Update Posted: 2021-10-08
First Post: 2019-04-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-05-07
Start Date Type: ACTUAL
Primary Completion Date: 2019-11-19
Primary Completion Date Type: ACTUAL
Completion Date: 2019-11-19
Completion Date Type: ACTUAL
First Submit Date: 2019-04-08
First Submit QC Date: None
Study First Post Date: 2019-04-10
Study First Post Date Type: ACTUAL
Results First Submit Date: 2020-11-06
Results First Submit QC Date: None
Results First Post Date: 2020-12-04
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-10-07
Last Update Post Date: 2021-10-08
Last Update Post Date Type: ACTUAL